Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 61.10
+0.65 (1.08%)
Aug 20, 2026, 4:09 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 60.92 billion as of August 20, 2026. Its market cap has increased by 529.82% in one year.
Market Cap
60.92B
Enterprise Value
60.66B
Revenue
1.78B
Ranking
n/a
PE Ratio
75.04
Stock Price
61.10
ChartMarket Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 60.92B, an increase of 490.71%. That is a compound annual growth rate of 56.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 58.22B | 146.84% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovent Biologics | 166.00B |
| Sichuan Kelun-Biotech Biopharmaceutical | 124.89B |
| Sino Biopharmaceutical | 85.64B |
| Akeso | 83.36B |
| RemeGen | 71.99B |
| Genscript Biotech | 57.03B |
| 3SBio | 43.54B |
| Shanghai Junshi Biosciences | 40.02B |